Close Menu
Home » With Global IP Secured, ImmunID Outlines Plans for PCR-Based Cancer Companion Test Market

With Global IP Secured, ImmunID Outlines Plans for PCR-Based Cancer Companion Test Market

Dec 18, 2015
|
Madeleine Johnson
Premium

NEW YORK (GenomeWeb) – ImmunID announced this week it has obtained patent protection in China, adding to IP in Europe, Japan, and the US, and completing a global IP strategy protecting the firm's technology base.

Headquartered in Grenoble, France, ImmunID is developing a method called ImmuneTracker for profiling T cell repertoires as a companion test for immune checkpoint inhibitors.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Ah, That's What It Is

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

Billions Requested

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

What to Do

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

PNAS Papers on Heart Transplant Rejection, CAR-T Profiling, Thiopurine Toxicity Variants

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.

Feb
27
Featured Webinar

Digital PCR Method Development for Accurate Quantification of Copy Number Variations

Sponsored by
Stilla

Since the publication of the “The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments” (dMIQE) in 2013, there has been a large expansion of the applications of dPCR such as single nucleotide variations (SNVs) and copy number variations (CNVs) measurements associated with disease diagnostics.

Mar
18
Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar
31
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In PCR

  1. Co-Diagnostics SARS-CoV-2 Assay Garners CE Mark

  2. New T2 Biosciences CEO Plans to Shrink Costs, Sharpen Sales Strategy

    Premium

  3. T2 Biosystems Q4 Revenues Jump 71 Percent, Miss Analyst Estimates

  4. Asuragen Fragile X Diagnostic Test Gets FDA Authorization

  5. Swift Biosciences, LGC BioSearch Partner on Targeted Sequencing for Ag-Bio

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.